Summary by Futu AI
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on February 9, 2024, disclosing its share repurchase activities for the period from December 19, 2023 to February 9, 2024. According to the report, the company repurchased a total of 67,100,000 shares of common stock during this period, representing 6.1722% of the issued shares. The last repurchase took place on 9 February 2024 and repurchased 344,000 shares at a price of between HKD 1.7 and HKD 1.75 per share at a total cost of HKD 601,130. The repurchased shares were not written off, leaving the number of outstanding shares as of February 9, 2024 at 1,044,821,000 shares. The Company confirms that all repurchases have been formally authorized by the Board of Directors and comply with the relevant provisions of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.